Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-08-2022 | Hysterectomy | Case report

Catequentinib/nedaplatin/paclitaxel

Various toxicities: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Zhai C-Y, et al. Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. World Journal of Clinical Cases 10: 7474-7482, No. 21, 26 Jul 2022. Available from: URL: http://doi.org/10.12998/wjcc.v10.i21.7474 Zhai C-Y, et al. Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. World Journal of Clinical Cases 10: 7474-7482, No. 21, 26 Jul 2022. Available from: URL: http://​doi.​org/​10.​12998/​wjcc.​v10.​i21.​7474
Metadata
Title
Catequentinib/nedaplatin/paclitaxel
Various toxicities: case report
Publication date
01-08-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-21110-3

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Oxycodone abuse

Case report

Rituximab

Case report

Adalimumab